This is a limited company view. Sign up for a Free Trial to see everything.

PharmAbcine develops fully human therapeutic monoclonal antibodies for the treatment of cancer and inflammatory diseases.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Daejeon

Founded

Employees

0

Stage

Series A

Total funding

$6M

Last funding

8 years ago

Acquisitions

0

Growth score

33

Mindshare score

33

Scoring

Employee Growth

Use PharmAbcine's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use PharmAbcine's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial